Title : Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis.

Pub. Date : 2010 Jul

PMID : 20610349

1 Functional Relationships(s)
Compound Name
Protein Name
1 In June, 2009, a panel of experts in MS and NAbs to interferon-beta therapy convened in Amsterdam, Netherlands, under the auspices of the Neutralizing Antibodies on Interferon beta in Multiple Sclerosis consortium, a European-based project of the 6th Framework Programme of the European Commission, to review and discuss data on NAbs and their practical consequences for the treatment of patients with MS on interferon beta. nabs interferon beta 1 Homo sapiens